As a result, GPs will be forced to justify their
prescription costs against newly published data, allowing managers to identify
those doctors who continue to prescribe expensive branded drugs rather than
their generic alternatives. The move comes after a study, backed by the new NHS
Commissioning Board, found the NHS was wasting £33m a month on unnecessary
expenditure on two branded heart drugs alone.
…/…
One former doctor told The Independent that part of the
problem lay with GP practices with on-site pharmacies. These make money for the
doctors working in the practice and because the profit margins on branded drugs
are substantially higher, this provides an incentive to prescribe more
expensive drugs.
"One of our neighbouring practices had a pharmacy
attached to it and routinely its drugs bill was always substantially higher
than ours despite having a very similar patient profile," he said.
"The suspicion always was that they were making money by prescribing the
drugs with the highest profit margin."
Ver: The INDEPENDENT
No hay comentarios:
Publicar un comentario